Stephen C. Yang, MD, FACS | Authors


Reversing the Surgical Stigma for Small-Cell Lung Cancer

October 15, 2010

Just as in recent years attitudes and treatment therapies have changed regarding non–small-cell lung cancer (NSCLC), it is time that the same occur for its small-cell counterpart. Although treatment for advanced-stage small-cell lung cancer (SCLC) is fairly standardized, there remain a number of controversies that have yet to be clarified by evidence-based data.

Commentary (Yang): Surgical Treatment of Metastatic Pulmonary Soft-Tissue Sarcoma

June 01, 2000

The criteria for successfully resecting pulmonary metastasis have not changed since they were originally described by Ehrenhaft in 1958.[1] They are (1) that the primary tumor site has been removed without evidence of local recurrence, (2) that no extrathoracic organ metastasis exists, and (3) that pulmonary disease has been completely removed without compromising pulmonary function.